Richard Piazza

Richard is a serial healthcare CEO who has been involved in entrepreneurial concerns for more than thirty years. He has raised more than $120MM in institutional and angel capital and has run device, biotech, and provider companies. Richard is the former CEO of Vital Therapies (NASD: VTL) and led the successful divestiture of SoloPak Pharmaceuticals for Smith & Nephew. Mr. Piazza has a close relationship with M.D. Anderson and a deep network across the global oncological community.